recurrent

MADRID -- Immunotherapy, chemotherapy, and a PARP inhibitor in the first line improved progression-free survival…

JEMPERLI is the first immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapyU.S. Food and Drug Administration approval…

- Blood-based test differentiates between ABMR and IgAN, enabling faster and more effective treatment- Improved utility over standard of care tests- Paper published in peer-reviewed journal…

A study presented at the recent American Society of Clinical Oncology (ASCO) annual meeting…

CHICAGO – Nearly three-fourths of people with type 1 diabetes (T1D) who engaged in aerobic activity failed to follow…

Elana Gotkine FRIDAY, June 9, 2023 (HealthDay News) -- A new locally recurrent rectal cancer (LRRC) quality of life (QoL) measure is a valid…

Bangalore: Fortis Hospital Bannerghatta successfully performed India’s novel Intraoperative Radiation Therapy (IORT) procedure on a…

Newark, New Castle, USA, May 26, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for recurrent vulvovaginal candidiasis in 2022 to be worth US$ 1.02…

CHICAGO -- Patients receiving vedolizumab (Entyvio) after undergoing bowel resection for advanced Crohn's disease in a…

Treatment with prednisone did not improve live birth rates among women with recurrent…